Steering Committee of the Helmholtz Alliance on Immuntherapy of Cancer
Table of Contents
Prof. Dr. Peter H. Krammer
Prof. Dr. Peter H. Krammer is member of the steering committee and also scientific coordinator of the Helmholtz Alliance on Immunotherapy of Cancer.
At the German Cancer Research Center he is coordinator of the research program Tumor Immunology and head of the division Immunogenetics. Since 2010, he is also one of the directors of the National Center for Tumor Diseases Heidelberg.
Prof. Krammer has a long and outstanding expertise in investigating the mechanisms of apoptosis and the role of apoptosis in the immune system and in disease.
Further Information
Prof. Dr. Christof von Kalle
Prof. Dr. Christof von Kalle is one of the directors of the National Center for Tumor Diseases at Heidelberg and coordinator of the research program Translational Oncology at the German Cancer Research Center Heidelberg. Scientifically, Prof. von Kalle has a longstanding expertise in stem cell physiology and therapeutic gene transfer.
Further Information
Prof. Dr. Dolores Schendel
Prof. Dr. Schendel is head of the Institute for Molecular Immunology at the Helmholtz Zentrum München - German Research Center for Environmental Health. Her major research interest is to define the molecular and cellular basis of anti-tumor immunity, with particular emphasis on T cell recognition. Based on these findings new immuno-therapies are developed for clinical trials.
Further Information
Prof. Dr. Michael Manns
Prof. Dr. Michael Manns is director of the Deparment of Gastroenterology, Hepatology and Endocrinology at the Medical School Hannover. He has a longstanding expertise in new therapeutical approaches of viral induced hepatitis and hepatocellular carcinoma.
Further Information
Prof. Dr. Martin Lipp
Prof. Dr. Martin Lipp is coordinator of the research program Tumor Immunology and head of the department Tumor Genetics at the Max Delbrück Center for Molecular Medicine in Berlin. His group is interested in the field of immune regulation, immunopathogenesis, tumor genetics and translational immunology with particular emphasis on chemokine receptors.
